Clinical Trial

The Effects of Holmium Laser Enucleation and Thulium Laser Enucleation on Continence, Urethral Stricture, and Sexual Function in Benign Prostatic Hyperplasia

Study acronym: EHTCUS
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 12, 2026 (before its estimated August 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study aims to evaluate the effects of Holmium Laser Enucleation of the Prostate (HoLEP) and Thulium Laser Enucleation of the Prostate (ThuLEP), performed for the treatment of benign prostatic hyperplasia (BPH), on the following parameters: urinary continence, development of urethral or bladder neck stricture, and sexual function, including erectile function, ejaculation, and libido.
Trial Details
NCT Number NCT07334730
Lead Sponsor TC Erciyes University
Conditions Benign Prostate Obstruction (BPO)
Enrollment 200 participants
Start Date 2026-02-01
Primary Completion 2026-08-01 (estimated)
Study Completion 2026-10-01 (estimated)
Updated on ClinicalTrials.gov 2026-01-12